Rights and permissions
About this article
Cite this article
Cetuximab failure means bevacizumab still best biologic. Inpharma Wkly. 1657, 16 (2008). https://doi.org/10.2165/00128413-200816570-00044
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816570-00044